FY2025 · period end Dec '25 · from the 10-K filed Feb 11, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $48.19B | $48.30B | $45.01B | $46.16B | $46.38B |
| Gross Profit | $34.26B | $34.33B | $34.31B | $36.02B | $36.45B |
| Operating Income | — | — | — | — | — |
| Net Income | $7.05B | negative: -$8.95B | $8.03B | $6.33B | $6.99B |
| EPS (Diluted) | $3.46 | negative: -$4.41 | $3.86 | $2.95 | $3.12 |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $90.04B | $92.60B | $95.16B | $96.82B | $109.31B |
| Total Liabilities | $71.53B | $76.22B | $65.67B | $65.70B | $73.31B |
| Stockholders' Equity | $18.51B | $16.39B | $29.48B | $31.12B | $36.01B |
| Cash & Equivalents | $10.21B | $10.35B | $11.46B | $9.12B | $13.98B |
| Total Debt | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $14.16B | $15.19B | $13.86B | $13.07B | $16.21B |
| Capital Expenditures | $1.31B | $1.25B | $1.21B | $1.12B | $0.97B |
| Free Cash Flow | $12.85B | $13.94B | $12.65B | $11.95B | $15.23B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | 71.1% | 71.1% | 76.2% | 78.0% | 78.6% |
| Operating Margin | — | — | — | — | — |
| Net Margin | 14.6% | negative: -18.5% | 17.8% | 13.7% | 15.1% |
| Return on Equity | 38.1% | negative: -54.6% | 27.2% | 20.3% | 19.4% |
| Return on Assets | 7.8% | negative: -9.7% | 8.4% | 6.5% | 6.4% |
| Debt / Equity | — | — | — | — | — |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
Who is buying and selling BRISTOL MYERS SQUIBB CO — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on BMY yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on BMY and publish the result to your public profile.
Ask about BRISTOL MYERS SQUIBB CO
Continue in Workspace — cited answers on BMY, a thesis you can score, or a signal on the next filing.
Open in WorkspaceGet 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs